Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 34,611 | 39,376 | 4,081 | 4,767 | 4,231 |
| Gross Profit | 34,611 | 39,376 | 4,081 | 4,767 | 4,231 |
| Operating Expenses | 38,630 | 32,797 | 31,775 | 33,451 | 30,224 |
| Operating Income | -4,019 | 6,579 | -27,694 | -28,684 | -25,993 |
| Interest Expense | 0 | -691 | 0 | 0 | 0 |
| Other Income | 670 | 0 | 1,039 | 859 | 983 |
| Pre-tax Income | -3,349 | 7,270 | -26,655 | -27,825 | -25,010 |
| Income Tax | N/A | N/A | N/A | -741 | -15 |
| Net Income Continuous | -3,349 | 7,270 | -26,655 | -27,084 | -24,995 |
| Net Income | $-3,349 | $7,270 | $-26,655 | $-27,084 | $-24,995 |
| EPS Basic Total Ops | -1.08 | 2.52 | -9.12 | -11.88 | -11.52 |
| EPS Basic Continuous Ops | -1.13 | 2.47 | -9.12 | -11.77 | -11.58 |
| EPS Diluted Total Ops | -1.08 | 2.28 | -9.12 | -11.88 | -11.52 |
| EPS Diluted Continuous Ops | -1.13 | 2.34 | -9.12 | -11.77 | -11.58 |
| EBITDA(a) | $-3,858 | $6,735 | $-27,714 | $-28,799 | $-26,238 |